{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-014013","form_type":"8-K","ticker":"FORA","cik":"0001829280","company_name":"Forian Inc.","filed_at":"2023-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.881011+00:00","generated_at":"2026-06-17T15:28:13.060279+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Forian Q4 revenue up 37% YoY to $7.9M; divests BioTrack for $30M; guides FY2023 rev $20.5-22.5M","bullets":["Q4 2022 revenue $7.9M (+37% YoY); net loss $3.6M vs $8.0M; adj. EBITDA -$0.9M vs -$4.5M.","Full year 2022 revenue $28.0M (+66% YoY); net loss $26.0M vs $26.6M; healthcare info rev grew 130% to $16.4M.","In February 2023, completed sale of BioTrack for $30M cash, strengthening balance sheet.","FY2023 guidance: healthcare info rev growth 25-37%, total rev $20.5-22.5M; positive adj. EBITDA expected in H2 2023.","Cash, equivalents and marketable securities at Dec 31, 2022 were $20.7M, boosted by BioTrack proceeds post-period."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-014013","json":"https://secwatch.observer/filing/0001140361-23-014013.json","markdown":"https://secwatch.observer/filing/0001140361-23-014013.md","text":"https://secwatch.observer/filing/0001140361-23-014013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1829280/000114036123014013/0001140361-23-014013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1829280/000114036123014013/brhc10050309_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T15:28:13.060279+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"148b2d600d62d67714583888c216e50149ecda53","claim":"Forian Inc. reported the three months ended December 31, 2022 results: revenue $ 7,903,992, net income $ (3,556,714 ), EPS $ (0.11 ).","evidence_excerpt":"Forian delivered the following results for the fourth quarter of 2022: Three Months Ended December 31, Period-over- 2022 2021 Period Unaudited Unaudited % Change Total revenues $ 7,903,992 $ 5,749,366 37% Net loss $ (3,556,714 ) $ (8,048,790 ) 56% Basic and diluted net loss per common share $ (0.11 ) $ (0.22 ) 51%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036123014013/0001140361-23-014013-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended December 31, 2022"},{"label":"Revenue","value":"$ 7,903,992"},{"label":"Net income","value":"$ (3,556,714 )"},{"label":"EPS","value":"$ (0.11 )"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"cb70b4af2605e3020e42e1d79b664f9a673dfc26","claim":"Forian Inc. reported the twelve months ended December 31, 2022 results: revenue $ 28,005,857, net income $ (25,971,971 ), EPS $ (0.81 ).","evidence_excerpt":"Forian delivered the following results for the full year of 2022: Twelve Months Ended December 31, Period-over- 2022 2021 Period Unaudited Unaudited % Change Total revenues $ 28,005,857 $ 16,879,715 66% Net loss $ (25,971,971 ) $ (26,551,105 ) 2% Basic and diluted net loss per common share $ (0.81 ) $ (0.90 ) 10%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036123014013/0001140361-23-014013-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the twelve months ended December 31, 2022"},{"label":"Revenue","value":"$ 28,005,857"},{"label":"Net income","value":"$ (25,971,971 )"},{"label":"EPS","value":"$ (0.81 )"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}